Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Pacira BioSciences granted inducement equity awards on September 2, 2026 to five new employees under its Amended and Restated 2014 Inducement Plan, approved without stockholder vote per Nasdaq Listing Rule 5635(c)(4). The awards comprise stock options on an aggregate 8,900 shares for three employees and restricted stock units covering an aggregate 14,000 shares for five employees, with options carrying a $26.58 exercise price, 10-year term, and four-year vesting.
Key figures
- Grantees
- 5
- Grant date
- 2026-09-02
- Rsu shares
- 14000
- Option shares
- 8900
- Exercise price
- 26.58
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.